Literature DB >> 10155692

Acetabular defect classification: a detailed radiographic approach.

M S Bradford1, W G Paprosky.   

Abstract

This classification system was developed based on clinically significant recurrent patterns of acetabular bone loss. The classification has now been refined with four specific radiographic parameters that provide specific criteria to classify each defect accurately. This detailed radiographic analysis is based on findings on the plain anterior-posterior pelvis radiograph and eliminates the need for costly computed tomography scans. Each defect classification type also has a clinically proven reconstruction method available. The failed acetabulum can be assessed accurately and easily with this method.

Entities:  

Mesh:

Year:  1995        PMID: 10155692

Source DB:  PubMed          Journal:  Semin Arthroplasty        ISSN: 1045-4527


  5 in total

1.  Complications of total hip arthroplasty: periprosthetic fractures of the acetabulum.

Authors:  Amol Chitre; Henry Wynn Jones; Nikhil Shah; Anthony Clayson
Journal:  Curr Rev Musculoskelet Med       Date:  2013-12

Review 2.  Clinical evaluation and surgical options in acetabular reconstruction: A literature review.

Authors:  Asim Qamar Ahmad; Ran Schwarzkopf
Journal:  J Orthop       Date:  2015-11-02

3.  Single-stage Acetabular Revision During Two-stage THA Revision for Infection is Effective in Selected Patients.

Authors:  Bernd Fink; Michael Schlumberger; Damian Oremek
Journal:  Clin Orthop Relat Res       Date:  2017-03-28       Impact factor: 4.176

4.  Tantalum augments for Paprosky IIIA defects remain stable at midterm followup.

Authors:  Daniel J Del Gaizo; Vamsi Kancherla; Scott M Sporer; Wayne G Paprosky
Journal:  Clin Orthop Relat Res       Date:  2012-02       Impact factor: 4.176

5.  Acetabular distraction: an alternative for severe defects with chronic pelvic discontinuity?

Authors:  Scott M Sporer; John J Bottros; Jonah B Hulst; Vamsi K Kancherla; Mario Moric; Wayne G Paprosky
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.